ES262656A1 - Mejoras introducidas en la preparaciën de vacunas - Google Patents

Mejoras introducidas en la preparaciën de vacunas

Info

Publication number
ES262656A1
ES262656A1 ES0262656A ES262656A ES262656A1 ES 262656 A1 ES262656 A1 ES 262656A1 ES 0262656 A ES0262656 A ES 0262656A ES 262656 A ES262656 A ES 262656A ES 262656 A1 ES262656 A1 ES 262656A1
Authority
ES
Spain
Prior art keywords
toxoid
clostridium perfringens
containing clostridium
vaccines containing
ethylenediaminetetra
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0262656A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES262656A1 publication Critical patent/ES262656A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mejoras introducidas en la preparación de vacunas, que contienen beta-toxoide de Cl. Perfringens, según las cuales la vacuna se trata con un agente secuestrador para cationes metálicos.
ES0262656A 1959-11-23 1960-11-22 Mejoras introducidas en la preparaciën de vacunas Expired ES262656A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3974259A GB958575A (en) 1959-11-23 1959-11-23 Vaccines containing clostridium perfringens ª‰-toxoid

Publications (1)

Publication Number Publication Date
ES262656A1 true ES262656A1 (es) 1961-03-01

Family

ID=10411223

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0262656A Expired ES262656A1 (es) 1959-11-23 1960-11-22 Mejoras introducidas en la preparaciën de vacunas

Country Status (2)

Country Link
ES (1) ES262656A1 (es)
GB (1) GB958575A (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264588A (en) * 1979-05-10 1981-04-28 The Charles River Breeding Laboratories, Inc. Vaccine for Clostridium perfringens type E enterotoxemia of rabbits
US5648230A (en) * 1994-06-30 1997-07-15 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Endotoxin stabilizing agent, endotoxin composition and method for assaying endotoxin

Also Published As

Publication number Publication date
GB958575A (en) 1964-05-21

Similar Documents

Publication Publication Date Title
ES262656A1 (es) Mejoras introducidas en la preparaciën de vacunas
AU4923759A (en) Paste formulations of alkali metal salts of haloaryloxyyalkylcarboxylic acids
CA534389A (en) Preparation of alkali metal salts of diesters of phosphoric acid
GB933565A (en) N-isopropyl-n-benzyl-hydrazine
CA581371A (en) Derivatives of amino acid metal salts
CA589880A (en) Process for the preparation of water-soluble derivatives of physiologically active corticord hormones
ES249787A1 (es) Procedimiento para la obtencion de un nuevo derivado de la fonotiacina
CA587269A (en) Preparation of alkali metal phosphates
CA573995A (en) Process for preparation of sodium oxides
CA559412A (en) Preparation of concentrated solutions of alkali metal salts of alkylchlorophenoxyacetic acids
CA644745A (en) Stable preparations of alkali metal salts of estrone sulfate
FR1604555A (en) Antiviral preparations containing elanolic acid derivatives
CA576286A (en) Preparation of peracetic acid
CA539061A (en) Preparation of gentisic acid and its alkali metal and ammonium salts
CA539060A (en) Preparation of gentisic acid and its alkali metal and ammonium salts
CA581341A (en) Preparation of salts of hydroxy aliphatic sulfonic acids
CA602849A (en) Alkali metal salts and alkaline earth metal salts of n1-glucuronoside-n2-isonicotinylhydrazine and a process for preparing the same
CA587225A (en) Separation of metal salts from their aqueous solutions
CA632961A (en) Method of preparing diamine-n,n'-bis-phosphoric acid derivatives
CA633170A (en) Fermentative preparation of 1-glutamic acid
AU202114B2 (en) Aqueous pharmaceutical solution
CA517153A (en) Preparation of n-substituted and n,n-disubstituted beta-amino-saturated aliphatic monocarboxylic acids
CA585078A (en) Method of producing stable alkali metal peroxide
CA525332A (en) Process for the preparation of pharmaceutical preparations active as an antacidum
CA604551A (en) Racemic pantothenic acid and metal salts of racemic pantothenic acid